CHARLES RIVER LABORATORIES INTERNATIONAL, INC. acquired Explora BioLabs Holdings, Inc. for $284.5 million, net of $6.6 million cash, a transaction completed in April 2022, structured as all cash.
Explora BioLabs Holdings, Inc. operates in Research Models and Services (RMS) — Insourcing Solutions, is based in United States (San Diego, California). Explora BioLabs was a provider of contract vivarium research services, providing biopharmaceutical clients with turnkey in vivo vivarium facilities, management and related services to efficiently conduct their early-stage research activities.
The acquisition of Explora BioLabs complements our existing Insourcing Solutions business, specifically our CRADL (Charles River Accelerator and Development Lab) footprint, and offers incremental opportunities to partner with an emerging client base. The purchase price of Explora BioLabs was $284.5 million, net of $6.6 million in cash.
RMS segment, Insourcing Solutions (CRADL)
The acquisition of Explora BioLabs complements our existing Insourcing Solutions business, specifically our CRADL (Charles River Accelerator and Development Lab) footprint, and offers incremental opportunities to partner with an emerging client base. The purchase price of Explora BioLabs was $284.5 million, net of $6.6 million in cash.Charles River FY2022 10-K, Business Acquisitions note
Advisory firms were not disclosed for this transaction.